chr16-9763583-C-G

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 1P and 7B. PP2BP4_ModerateBP6BS2

The ENST00000330684.4(GRIN2A):ā€‹c.3961G>Cā€‹(p.Glu1321Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,613,808 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000046 ( 0 hom., cov: 32)
Exomes š‘“: 0.0000096 ( 0 hom. )

Consequence

GRIN2A
ENST00000330684.4 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 4.42
Variant links:
Genes affected
GRIN2A (HGNC:4585): (glutamate ionotropic receptor NMDA type subunit 2A) This gene encodes a member of the glutamate-gated ion channel protein family. The encoded protein is an N-methyl-D-aspartate (NMDA) receptor subunit. NMDA receptors are both ligand-gated and voltage-dependent, and are involved in long-term potentiation, an activity-dependent increase in the efficiency of synaptic transmission thought to underlie certain kinds of memory and learning. These receptors are permeable to calcium ions, and activation results in a calcium influx into post-synaptic cells, which results in the activation of several signaling cascades. Disruption of this gene is associated with focal epilepsy and speech disorder with or without cognitive disability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), GRIN2A. . Gene score misZ 2.8278 (greater than the threshold 3.09). Trascript score misZ 3.7088 (greater than threshold 3.09). GenCC has associacion of gene with early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation, Landau-Kleffner syndrome, continuous spikes and waves during sleep, complex neurodevelopmental disorder, rolandic epilepsy-speech dyspraxia syndrome, childhood epilepsy with centrotemporal spikes.
BP4
Computational evidence support a benign effect (MetaRNN=0.07401371).
BP6
Variant 16-9763583-C-G is Benign according to our data. Variant chr16-9763583-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 205681.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=3}.
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GRIN2ANM_001134407.3 linkuse as main transcriptc.3961G>C p.Glu1321Gln missense_variant 13/13 ENST00000330684.4 NP_001127879.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GRIN2AENST00000330684.4 linkuse as main transcriptc.3961G>C p.Glu1321Gln missense_variant 13/131 NM_001134407.3 ENSP00000332549 P1Q12879-1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152106
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000399
AC:
10
AN:
250932
Hom.:
0
AF XY:
0.0000295
AC XY:
4
AN XY:
135654
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.000145
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000352
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000958
AC:
14
AN:
1461584
Hom.:
0
Cov.:
33
AF XY:
0.00000550
AC XY:
4
AN XY:
727122
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000179
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000450
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152224
Hom.:
0
Cov.:
32
AF XY:
0.0000672
AC XY:
5
AN XY:
74418
show subpopulations
Gnomad4 AFR
AF:
0.0000722
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000603
Hom.:
0
Bravo
AF:
0.0000718
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000494
AC:
6
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Landau-Kleffner syndrome Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitterclinical testingNew York Genome CenterMay 19, 2020- -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 12, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingNew York Genome CenterJul 22, 2019The c.3961G>C (p.Glu1321Gln) variant identified in the GRIN2A gene substitutes a conserved Glutamic acid for Glutamine at amino acid 1321/1465 (coding exon 13/13). This variant is identified in gnomAD (10 heterozygotes, 0 homozygoutes; allele frequency:3.985e-5), and ExAC (6 heterozygotes, 0 homozygotes; allele frequency: 4.956e-5). In silico algorithms predict this variant to be Neutral (Proven; score: -0.90) and Tolerated (SIFT; score: 0.244) to the function of the canonical transcript. This variant is reported as a Variant of Uncertain Significance in ClinVar (VarID: 205681; 2 stars), and to our current knowledge has not been reported in affected individuals in the literature. The p.Glu1321 residue is within the C-terminal domain of GRIN2A, which is involved in signal mediation [PMID: 30544257], however the C-terminal domain is not associated with an increased burden of pathogenic variants, and benign missense variants within this domain are found in healthy individuals in population databases. Given the lack of compelling evidence for the pathogenicity of this variant, the c.3961G>C (p.Glu1321Gln) variant is reported here as a Variant of Uncertain Significance.AS34 -
not provided Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingAthena DiagnosticsDec 27, 2018- -
Likely benign, criteria provided, single submitterclinical testingGeneDxMar 18, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
21
DANN
Uncertain
0.97
DEOGEN2
Uncertain
0.42
T;T
Eigen
Benign
0.0022
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.74
.;T
M_CAP
Benign
0.0038
T
MetaRNN
Benign
0.074
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.88
L;L
MutationTaster
Benign
1.0
D;D;D;N;N;N
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.90
N;N
REVEL
Benign
0.077
Sift
Benign
0.24
T;T
Sift4G
Benign
0.17
T;T
Polyphen
0.024
B;B
Vest4
0.040
MVP
0.55
MPC
0.26
ClinPred
0.051
T
GERP RS
5.5
Varity_R
0.16
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs370754278; hg19: chr16-9857440; API